Dominick Colangelo's Net Worth

$33.4 Million

Estimate Recalculated Nov 1, 2024 10:01AM EST

Who is Dominick Colangelo

Dominick Colangelo has an estimated net worth of $33.4 Million. This is based on reported shares across multiple companies, which include Vericel Corp, Trevi Therapeutics, Inc., and OSCIENT PHARMACEUTICALS CORP.

SEC CIK

Dominick Colangelo's CIK is 0001313403

Past Insider Trading and Trends

2024 was Dominick Colangelo's most active year for acquiring shares with 49 total transactions. Dominick Colangelo's most active month to acquire stocks was the month of January. 2021 was Dominick Colangelo's most active year for disposing of shares, totalling 20 transactions. Dominick Colangelo's most active month to dispose stocks was the month of January. 2015 saw Dominick Colangelo paying a total of $1,328,800.00 for 440,000 shares, this is the most they've acquired in one year. In 2021 Dominick Colangelo cashed out on 184,201 shares for a total of $7,287,298.34, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vericel Corp

President and CEO
Updated Oct 18, 2024
Form 4
13.68%
35.00K
$21.94
-$1.32M
Oct 18, 2024
255.94K
Sell-Options
Oct 16 - Oct 17
Form 4
12.03%
35.00K
$23.33
-$1.42M
Sep 13, 2024
290.94K
Sell-Options
Sep 11 - Sep 12
Form 4
10.74%
35.00K
$24.37
-$1.49M
Aug 16, 2024
325.94K
Sell-Options
Aug 14 - Aug 15
Form 4
9.70%
35.00K
$27.25
-$1.70M
Jul 19, 2024
360.94K
Sell-Options
Jul 17 - Jul 18
Form 4
8.84%
35.00K
$23.32
-$1.42M
Jun 14, 2024
395.75K
Sell-Options
Jun 12 - Jun 13
Form 4
8.13%
35.00K
$25.89
-$1.60M
May 17, 2024
430.75K
Sell-Options
May 15 - May 16
Form 4
5.23%
50.89K
$11.79
$299.98K
May 01, 2024
1.02M
Options
Apr 30
Form 4
7.95%
35.00K
$24.28
-$1.49M
Apr 19, 2024
440.31K
Sell-Options
Apr 17 - Apr 18
Form 4
7.37%
35.00K
$23.69
-$1.45M
Mar 15, 2024
474.87K
Sell-Options
Mar 13 - Mar 14
Form 4
255.50K
Feb 26, 2024
255.50K
Grant
Feb 22
Form 4
26.89%
59.75K
$49.50
-$892.24K
Feb 22, 2024
281.96K
Options
Feb 20
Form 4
7.16%
35.00K
$25.47
-$1.57M
Feb 16, 2024
489.01K
Sell-Options
Feb 14 - Feb 15
Form 4
7.09%
11.52K
$47.42
-$164.88K
Feb 13, 2024
174.01K
Options
Feb 12
Form 4
6.43%
33.45K
$20.65
-$1.18M
Jan 19, 2024
519.99K
Sell-Options
Jan 17 - Jan 18
Form 4
9.76%
17.24K
$19.58
-$768.12K
Dec 15, 2023
169.99K
Sell-Options
Dec 13 - Dec 14
Form 4
12.18%
24.40K
$18.86
-$745.81K
Dec 08, 2023
200.74K
Sell-Options
Dec 06 - Dec 07
Form 4
32.12%
245.93K
$29.82
-$285.26K
Feb 22, 2023
1.01M
Options
Feb 17 - Feb 19
Form 4
-2.00%
-3.52K
$29.30
-$102.99K
Feb 14, 2023
172.24K
Options
Feb 11
Form 4
-1.98%
-3.25K
$30.60
-$99.54K
Feb 08, 2023
160.75K
Options
Feb 06
Form 4
-20.27%
-39.94K
$26.47
-$53.20K
Jan 12, 2023
157.07K
Sale
ScheduledJan 10
Form 4
168.84%
315.93K
$34.90
-$447.14K
Feb 22, 2022
503.05K
Options
Feb 18 - Feb 19
Form 4
-1.92%
-3.25K
$35.26
-$379.08K
Feb 15, 2022
166.37K
Options
Feb 11
Form 4
-1.94%
-3.05K
$33.91
-$338.63K
Feb 08, 2022
154.06K
Options
Feb 06
Form 4
-17.94%
-40.00K
$41.91
-$2.13M
Apr 20, 2021
182.91K
Sale
ScheduledApr 19
Form 4
-15.24%
-40.00K
$38.41
-$1.85M
Mar 30, 2021
222.55K
Sale
ScheduledMar 29 - Mar 30
Form 4
-6.47%
-40.00K
$25.96
-$1.82M
Mar 02, 2021
578.57K
Sale
ScheduledMar 01
Form 4
335.75K
Feb 22, 2021
335.75K
Grant
Feb 19
Form 4
-1.33%
-3.27K
$49.23
-$530.06K
Feb 12, 2021
241.70K
Options
Feb 11
Form 4
-1.33%
-3.08K
$47.18
-$472.55K
Feb 08, 2021
228.84K
Options
Feb 06
Form 4
$2.75
$36.09K
May 08, 2020
276.12K
Options
May 08
Form 4
$2.40
$56.20K
Feb 18, 2020
328.16K
Options
Feb 13
Form 4
255.00K
Feb 13, 2020
255.00K
Grant
Feb 11
Form 4
-1.62%
-3.18K
$17.28
-$174.80K
Feb 10, 2020
193.60K
Options
Feb 06
Form 4
$2.65
$149.06K
Oct 03, 2019
202.78K
Options
Oct 01 - Oct 02
Form 4
-22.12%
-58.13K
$8.82
-$704.81K
Oct 03, 2019
204.66K
Sale
ScheduledOct 01
Form 4
$2.76
$100.00K
Feb 19, 2019
558.30K
Options
Feb 15
Form 4
337.75K
Feb 08, 2019
337.75K
Grant
Feb 06
Form 4
-18.17%
-50.00K
$9.07
-$632.00K
Nov 08, 2018
225.16K
Sale
ScheduledNov 06
Form 4
-33.73%
-75.00K
$8.49
-$980.25K
Oct 09, 2018
147.35K
Sale
ScheduledOct 04
Form 4
-3.36%
-28.89K
$8.15
-$337.70K
May 18, 2018
831.70K
Sale
ScheduledMay 16 - May 17
Form 4
$3.13
$106.62K
Feb 22, 2018
532.30K
Options
Feb 20
Form 4
300.00K
Feb 09, 2018
300.00K
Grant
Feb 07
Form 4
90.00K
May 24, 2017
90.00K
Grant
May 22
Form 4
210.00K
Feb 10, 2017
210.00K
Grant
Feb 08
Form 4
165.00K
Feb 11, 2016
165.00K
Grant
Feb 09
Form 4
440.00K
$3.02
$1.33M
Jan 07, 2015
440.00K
Grant
Jan 05
Form 4
20.00K
$2.55
$51.00K
Sep 17, 2014
20.00K
Purchase
Sep 16
Form 4
55.00K
$3.57
$196.35K
Jan 08, 2014
55.00K
Grant
Jan 03
Form 3
Mar 08, 2013
Showing 49 results

Trevi Therapeutics, Inc.

Investor
Updated Jun 14, 2024
Form 4
30.00K
Jun 14, 2024
30.00K
Grant
Jun 13
Form 4
30.00K
Jun 30, 2023
30.00K
Grant
Jun 28
Form 4/A
20.00K
Jul 01, 2022
20.00K
Grant
Jun 23
Form 4
20.00K
Jun 23, 2022
20.00K
Grant
Jun 23
Form 4
20.00K
Jun 17, 2021
20.00K
Grant
Jun 16
Form 4
23.68K
Jul 01, 2020
23.68K
Grant
Jun 29
Form 3
Jul 01, 2020
Showing 7 results

OSCIENT PHARMACEUTICALS CORP

EVP Corporate Dev & Operations
Updated Mar 13, 2008
Form 4
161.34%
51.30K
Mar 13, 2008
83.10K
Grant
Feb 25
Form 4
6.71%
2.00K
$1.24
$2.48K
Feb 12, 2008
31.80K
Purchase
Feb 08
Form 4
668.30%
68.40K
Mar 09, 2007
78.64K
Grant
Mar 07
Form 4
280.00K
Mar 16, 2006
280.00K
Grant
Feb 27
Form 4
1.87K
$2.25
$4.22K
Jul 01, 2005
1.87K
Acq/Dis
Jun 30
Form 4
250.00K
$3.60
$900.00K
Jan 05, 2005
250.00K
Grant
Jan 03
Form 3
Jan 05, 2005
Showing 7 results